NH SPAC 8 (218410) - Total Liabilities
Based on the latest financial reports, NH SPAC 8 (218410) has total liabilities worth ₩142.61 Billion KRW (≈ $96.65 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NH SPAC 8 - Total Liabilities Trend (2016–2025)
This chart illustrates how NH SPAC 8's total liabilities have evolved over time, based on quarterly financial data. See NH SPAC 8 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
NH SPAC 8 Competitors by Total Liabilities
The table below lists competitors of NH SPAC 8 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Integra LifeSciences Holdings
NASDAQ:IART
|
USA | $2.54 Billion |
|
The India Cements Limited
NSE:INDIACEM
|
India | Rs32.79 Billion |
|
KCE Electronics Public Company Limited
BK:KCE
|
Thailand | ฿4.73 Billion |
|
Dogan Sirketler Grubu Holding AS
IS:DOHOL
|
Turkey | TL78.46 Billion |
|
Perpetual Ltd
AU:PPT
|
Australia | AU$1.74 Billion |
|
Sally Beauty Holdings Inc
NYSE:SBH
|
USA | $2.03 Billion |
|
UTI Asset Management Company Limited
NSE:UTIAMC
|
India | Rs5.39 Billion |
|
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
|
USA | $39.64 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down NH SPAC 8's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NH SPAC 8 stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NH SPAC 8's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NH SPAC 8 (2016–2025)
The table below shows the annual total liabilities of NH SPAC 8 from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩149.72 Billion ≈ $101.47 Million |
+19.79% |
| 2024-12-31 | ₩124.99 Billion ≈ $84.70 Million |
-30.99% |
| 2023-12-31 | ₩181.12 Billion ≈ $122.75 Million |
-10.18% |
| 2022-12-31 | ₩201.66 Billion ≈ $136.66 Million |
+20.99% |
| 2021-12-31 | ₩166.68 Billion ≈ $112.96 Million |
+44.62% |
| 2020-12-31 | ₩115.26 Billion ≈ $78.11 Million |
+88.56% |
| 2019-12-31 | ₩61.12 Billion ≈ $41.42 Million |
-21.34% |
| 2018-12-31 | ₩77.70 Billion ≈ $52.66 Million |
+143.18% |
| 2017-12-31 | ₩31.95 Billion ≈ $21.65 Million |
+1903.20% |
| 2016-12-31 | ₩1.60 Billion ≈ $1.08 Million |
-- |
About NH SPAC 8
RFHIC Corporation designs and manufactures radio frequency (RF) and microwave components for wireless infrastructure, commercial and military radar, and industrial/scientific/medical industries in South Korea and internationally. The company's products include RF power transistors comprising gallium nitride (GaN) on SiC transistors; GaN and GaAs MMICs, and active dividers; power amplifiers, such … Read more